NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA

Office for Artificial Intelligence UK Published: 2026-04-02 16:08:00

New partnership accelerates NHS patients' access to new medicines and will see UK benefit from greater life sciences industry investment.

No full content stored. Use “Open Source” to read the original.

Open Source →

Recommended reads

Notice: UK-Germany joint statement on advanced AI safety and security From UK

A joint statement by the UK and Germany on collaborating to ensure advanced AI is developed safely and its risks are rigorously understood and managed.

Office for Artificial Intelligence · UK 2026-06-30

Guidance: Person Data Standard: overview and guidance From UK

Learn about the Alpha Person Data Standard and how to provide feedback.

Office for Artificial Intelligence · UK 2026-06-30

Guidance: Person Standard Use Case: HMPPS Core Person Service From UK

Learn how the Person Data Standard can be applied in practice when a single authoritative identity is required for person data.

Office for Artificial Intelligence · UK 2026-06-30